Evaluating the Survival Benefit Following Ovarian Function Suppression in Premenopausal Patients with Hormone Receptor Positive Early Breast Cancer

There are divergent opinions regarding the use of ovarian function suppression or ablation (hereafter, OFS) in hormone receptor positive early breast cancer patients. In order to clarify the survival benefit of OFS, a meta-analysis was performed. The result is that use of OFS was more effective than...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Lin, Fu, Fangmeng, Huang, Meng, Lin, Yuxiang, chen, Yazhen, Chen, Minyan, Wang, Chuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4882507/
https://www.ncbi.nlm.nih.gov/pubmed/27230285
http://dx.doi.org/10.1038/srep26627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4882507/
https://www.ncbi.nlm.nih.gov/pubmed/27230285
http://dx.doi.org/10.1038/srep26627

Ejemplares similares